about
Growth inhibition and apoptosis induced by daunomycin-conjugated triplex-forming oligonucleotides targeting the c-myc gene in prostate cancer cellsDodecamer d-AGATCTAGATCT and a homologous hairpin form triplex in the presence of peptide REWERRegulating eukaryotic gene expression with aptamers.DNA binding and antigene activity of a daunomycin-conjugated triplex-forming oligonucleotide targeting the P2 promoter of the human c-myc gene.Beyond nucleic acid base pairs: from triads to heptads.Polypurine hairpins directed against the template strand of DNA knock down the expression of mammalian genes.The paperclip triplex: understanding the role of apex residues in tight turns.Fluorescent probes for nucleic Acid visualization in fixed and live cells.Cancer gene therapy.Transcription factor decoy (TFD) in breast cancer research and treatment.Improved synthesis strategy for peptide nucleic acids (PNA) appropriate for cell-specific fluorescence imagingOn future's doorstep: RNA interference and the pharmacopeia of tomorrow.Induced cross-linking reactions to target genes using modified oligonucleotides.Design of a novel triple helix-forming oligodeoxyribonucleotide directed to the major promoter of the c-myc gene.The potential of toxin-based drug delivery systems for enhanced nucleic acid therapeutic delivery.Tailoring the activity of restriction endonuclease PleI by PNA-induced DNA looping.Assessment of DNA damage produced by 125I-triplex-forming oligonucleotides in cells.Sequence-specific triple helix formation with genomic DNA.Highly stable DNA triplexes formed with cationic phosphoramidate pyrimidine alpha-oligonucleotides.
P2860
Q25257791-341C095E-2DAA-4F03-9B92-F5ED9C0B8395Q28533181-F55F0F98-71F6-4432-A8CF-AADA244DD0D4Q31067509-B74DB6AE-46B5-4E13-AC31-F3F6B73BBF81Q34325748-F2CCBD00-34A3-4E34-BEF1-4EA5FCA743D2Q34561390-299906A3-3439-44F6-8256-FC03DD8A3051Q34956681-CE6F3D7E-FD2E-4FDB-BE58-360133A21260Q35021462-1C23AACB-DAD2-4A21-A493-1F34B8B16044Q35066396-A7E5533E-5C29-468F-989F-01FCE885BA7BQ35081097-250FA5DE-3AA0-41BF-8573-495996D56B26Q35081110-734F22FB-ED1C-4C5D-A72D-CF571886BFFCQ35567325-13B7EE5D-C04B-4300-B775-60C659CD72C2Q36173624-E51F0B8D-3194-4A10-A6D1-7C34CDC99233Q37849605-198847D2-B5D6-430C-B812-A4B7F146FB7FQ38288224-E51FB888-DBCF-434D-9525-4697E46BF20FQ38934039-576781BC-E388-41DD-9F95-1E0061A59D86Q40399754-F3A6477F-6EC7-47E9-BBD4-5A648B70562CQ40447353-76E06556-BF93-4AC1-BDB7-8FC6629BAF2EQ41869793-BC9AB1CD-841F-4179-BA0E-8B4A59DEF2B2Q46506386-D53F52C5-2B03-4CC6-943D-6D8D5CA7424E
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Gene targeting via triple-helix formation.
@ast
Gene targeting via triple-helix formation.
@en
Gene targeting via triple-helix formation.
@nl
type
label
Gene targeting via triple-helix formation.
@ast
Gene targeting via triple-helix formation.
@en
Gene targeting via triple-helix formation.
@nl
prefLabel
Gene targeting via triple-helix formation.
@ast
Gene targeting via triple-helix formation.
@en
Gene targeting via triple-helix formation.
@nl
P1476
Gene targeting via triple-helix formation.
@en
P2093
P304
P356
10.1016/S0079-6603(01)67028-4
P577
2001-01-01T00:00:00Z